Glad I topped up in the lows. Still good at current price, compare to what it was last year. Could more than double in price by next year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025